WebJun 16, 2024 · As the BRD4 bromodomains bind acetylated lysine residues (Dey et al., 2024), chromatin immunoprecipitation sequencing (ChIP-seq) was performed to … WebJun 16, 2024 · Given the dramatic impact of Brd4 RNAi, the authors then investigated if BRD4 can be targeted at the protein level using small molecule inhibitors. The pan-BET bromodomain inhibitor JQ1 prevents all four BET proteins from binding acetylated lysine residues by blocking these proteins’ bromodomains (Boi et al., 2015; Filippakopoulos et …
靶向BET家族蛋白的药物开发 - 知乎 - 知乎专栏
WebJun 14, 2024 · The novel BRD4 degraders showed relatively strong potency against BRD4 BD1 with IC 50 at nanomolar concentrations. The anti-proliferative activity of PROTAC 5 against BxPC3 cell lines (IC 50 = 0.165 μM) was increased approximately 7-fold compared to ABBV-075. In addition, PROTAC 5 effectively degraded BRD4 and inhibited c-Myc … WebNov 9, 2024 · Bromodomain-containing protein 4 (BRD4) is an epigenetic reader and oncology drug target that regulates gene transcription through binding to acetylated chromatin via bromodomains. Phosphorylation ... marvin alexander facebook
An Overview on Small Molecule Inhibitors of BRD4
WebBRD4 has been used as a therapeutic target for various inhibitors that displace it from the chromatin (4, 8–16). However, BRD4 upstream regulation by posttranslational … WebMay 9, 2016 · In vitro and in vivo analyses show that BRD4 has intrinsic acetyltransferase activity targeting histones H3 and H4, and BRD4 acetylation of H3 K122 results in histone eviction, nucleosome ... WebJul 21, 2024 · BRD4, a Bromodomain and Extraterminal (BET) protein family member, is a promising anti-cancer drug target. However, resistance to BET inhibitors targeting BRD4 is common in solid tumors. Here, we ... huntingdon district council tax rebate